The Role of Interleukin-4 in the Negative Regulation of Leukemia Cell Growth

References

• Howard M., Farrar J., Hifiker M., Johnson B., Takatsu K., Hamaoka T., Paul W. E. Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 1982; 155: 914–923
   PubMed Web of Science ®Google Scholar
• Peschel C., Green I., Ohara J., Paul W. E. Role of B cell stimulatory factor 1/interleukin 4 on hematopoietic progenitor cells. Blood 1987; 70: 254–263
   PubMed Web of Science ®Google Scholar
• Ohara J., Paul W. E. Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage. Nature 1987; 325: 537–540
   PubMed Web of Science ®Google Scholar
• Kishi K., Ihle J. N., Urdal D. L., Ogawa M. Murine B-Cell stimulatory factor-1 (BSF-l)/interleukin-4 (IL-4) is a multilineage colony-stimulating factor that acts directly on primitive hemopoietic progenitors. J. Cell. Physiol. 1989; 139: 463–468
   PubMed Web of Science ®Google Scholar
• Sonoda Y., Okuda T., Yokota S., Maekawa T., Shizumi Y., Nishigaki H., Misawa S., Fujii H., Abe T. Actions of human interleukin-4/B-cell stimulatory factor-1 on proliferation and differentiation of enriched hematopoietic progenitor cells in culture. Blood 1990; 75: 1615–1621
   PubMed Web of Science ®Google Scholar
• Rennick D., Jackson Y., Yang G., Widerman J., Lee F., Hudak S. Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid, and multi-potential progenitor cells. Blood 1989; 73: 1828–1835
   PubMed Web of Science ®Google Scholar
• Jansen J. H., Wientjens H. M., Fibbe W. E., Willemze R., Kluin-Nelemans H. C. Inhibition of human macro-phage colony formation by interleukin 4. J. Exp. Med. 1989; 170: 577–582
   PubMed Web of Science ®Google Scholar
• Wolf J. T. M., Beentjes J. A. M., Esselink M. T., Smit J. W., Halie M. R. Interleukin-4 suppresses the interleukin-3 dependent erythroid colony formation from normal human bone marrow cells. Br. J. Haematol. 1990; 74: 246–250
   PubMed Web of Science ®Google Scholar
• Sillaber C., Strobl H., Bevec D., Ashman L. K., Butterfield J. H., Lechner K., Maurer D., Bettelheim P., Valent P. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J. Immunol. 1991; 147: 4224–4228
   PubMed Web of Science ®Google Scholar
• Essner R., Rhoades K., McBridge W. H., Norton D. J., Economou J. S. IL-4 down-regulates IL-1 and TNF gene expressions in human monocytes. J. Immunol. 1989; 142: 3857–3861
   PubMed Web of Science ®Google Scholar
• Hart H. P., Vitti F. G., Burgess D. R., Whitty G. A., Piccoli D. S., Hamilton J. A. Potential antiinflammatory effects of interleukin 4: Suppression of human monocyte tumor necrosis factor-alpha, interleukin 1, and prostaglandin E2. Proc. Natl. Acad. Sci. U.S.A. 1990; 86: 3803–3807
   Web of Science ®Google Scholar
• Gibbons R., Martinez O., Math M., Heinzel F., Bernstein M., Warren R. Recombinant IL-4 inhibits IL-6 synthesis by adherent peripheral blood cells in vitro. Lymphokine Res. 1990; 3: 283–293
   Google Scholar
• Te Velde A. A., Huijbens R. J. F., Heije K., De Vries J. E., Figdor C. G. Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 1990; 76: 1392–1397
   PubMed Web of Science ®Google Scholar
• Standiford T. E., Strieter R. M., Chensue S. W., Westwick J., Kasahara K., Kunkel S. L. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J. Immunol. 1990; 145: 1435–1439
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Young D., Herrmann F., Wiper D., Wagner K., Sabbath K. D. Effect of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia. Blood 1986; 67: 1448–1453
   PubMed Web of Science ®Google Scholar
• Vellenga E., Young D. C., Wagner K., Wiper D., Ostapovicz D., Griffin J. D. The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 1987; 69: 1771–1776
   PubMed Web of Science ®Google Scholar
• Vaughan W. P., Civin C. I., Weisenhurger D. D., Karp J. E., Graha M. M. L., Sanger W. G., Grierson H. L., Joshi S. S., Burke P. Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY 10). Leukemia 1988; 2: 661–666
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Gockerman J. P., Moore J. O., Civin C. I., Page S. O., Robertson J., Bigner S. H. Clinopathologic and cytogenetic features of CD34 (MY 10)-positive acute nonlymphocytic leukemia. Am. J. Clin. Pathol. 1989; 91: 265–270
   PubMed Web of Science ®Google Scholar
• Leary A. G., Ikebuchi K., Hirai Y., Wong G. G., Yang Y. C., Clark S. C., Ogawa M. Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: Comparison with interleukin-1. Blood 1988; 71: 1759–1763
   PubMed Web of Science ®Google Scholar
• Ikebuchi K., Wong G. G., Clark S. C., Ihle J. N., Hirai Y. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hematopoietic progenitors. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 9033–9039
   Web of Science ®Google Scholar
• Akashi K., Harada M., Shibuya T., Eto T., Takamatsu Y., Teshima T., Niho Y. Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34 - blasts from acute myelogenous leukemia. Blood 1991; 78: 197–204
   PubMed Web of Science ®Google Scholar
• Carlo-Stella C., Mangoni L., Almici C., Frassoni F., Fiers W., Rizzoli V. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic factors. Leukemia 1990; 4: 561–566
   PubMed Web of Science ®Google Scholar
• Tesser N., Hoang T. Transforming growth factor-beta inhibits the proliferation of the blast cells of acute myeloblastic leukemia. Blood 1988; 72: 159–164
   PubMed Web of Science ®Google Scholar
• Salem M., Delwel R., Touw I., Mahmoud L. A., Elbasousy E. M., Lowenberg B. Modulation of colony stimulating factor-(CSF) dependent growth of acute myeloid leukemia by tumor necrosis factor. Leukemia 1990; 4: 37–43
   PubMed Web of Science ®Google Scholar
• Oster W., Cicco N. A., Klein H., Hirano T., Hishimoto T., Lindemann A. Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J. Clin. Invest. 1989; 84: 451–457
   PubMed Web of Science ®Google Scholar
• Everson M. P., Brown C. B., Lily M. B. Interleukin 6 and granulocyte-macrophage colony-stimulating factor are candidate growth factor for chronic myelomonocytic leukemia cells. Blood 1989; 74: 1472–1476
   PubMed Web of Science ®Google Scholar
• Akashi K., Shibuya T., Harada M., Takamatsu Y., Uike N., Eto T., Niho Y. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells. J. Clin. Invest. 1991; 88: 223–230
   PubMed Web of Science ®Google Scholar
• Vellenga E., DeWolf J. T. M., Beentjes J. A. M., Esselink M. T., Smit J. W., Halie M. R. Divergent effects of interleukin-4 (IL-4) on the granulocyte colony-stimulating factor and IL-3-supported myeloid colony formation from normal and leukemic bone marrow cells. Blood 1990; 75: 633–637
   PubMed Web of Science ®Google Scholar
• Imai Y., Nara N., Tohda S., Nagata K., Suzuki T., Nagasawa M., Murohashi I., Aoki N. Antiproliferative and differentiative effects of the recombinant interleukin-4 on a granulocyte colony-stimulating factor-dependent myeloblastic leukemic cell line. Blood 1991; 78: 471–478
   PubMed Web of Science ®Google Scholar
• Imai Y., Tohda S., Nagata K., Suzuki T., Nara N., Aoki N. Effects of interleukin-4 on the growth and differentiation of blast progenitors stimulated with G-CSF, GM-CSF and IL-3 from acute myeloblastic leukaemia patients. Br. J. Haematol. 1991; 78: 173–179
   PubMed Web of Science ®Google Scholar
• Buhring H J., Ullrich A., Schaudt K., Muller C. A., Busch F. W. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hematopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 1991; 5: 854–860
   PubMed Web of Science ®Google Scholar
• Wang C., Koistinen P., Yang G. S., Williams D. E., Lyman S. D., Minden M. D., McCulloch E. A. Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia. Leukemia 1991; 5: 493–499
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Frandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Geissler K., Hinterberger W., Bettelheim P., Haas O., Lechner K. Colony growth characteristics in chronic myelomonocytic leukemia. Leukemia Res. 1988; 12: 373–378
   PubMed Web of Science ®Google Scholar
• Yuo A., Miyazono K., Takaku F. Characterization of granulocyte-Macrophage colony formation in chronic myelomonocytic leukemia: A comparative study with other myelodysplastic and myeloproliferative disorders. Jpn. J. Cancer Res. 1990; 81: 820–826
   PubMedGoogle Scholar
• Murohashi I., Tohda S., Suzuki T., Nagata K., Yamashita Y., Nara N. Autocrine growth mechanisms of the progenitors or blast cells in acute myeloblastic leukemia. Blood 1989; 74: 35–41
   PubMed Web of Science ®Google Scholar
• Taylor C. W., Grogan T. M., Salmon S. E. Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms. Blood 1990; 75: 1114–1118
   PubMed Web of Science ®Google Scholar
• Okabe M., Kuni-eda Y., Sugiwura T., Tanaka M., Miyagishima T., Saiki I., Minagawa T., Kurosawa M., Itaya T., Miyazaki T. Inhibitory effect of interleukin-4 on the in vitro growth of Ph1-positive acute lymphoblastic leukemia cells. Blood 1991; 78: 1574–1580
   PubMed Web of Science ®Google Scholar
• Defrance T., Fluckiger A C., Rossi J F., Magaud J P., Sotto J. J., Banchereau J. Antiproliferative effects of interleukin-4 on freshly isolated non-Hodgkin malignant B-lymphoma cells. Blood 1992; 79: 990–996
   PubMed Web of Science ®Google Scholar
• Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H., Kuramoto A., Kishimoto T. Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988; 332: 83–84
   PubMed Web of Science ®Google Scholar
• Klein B., Zhang X. G., Jourdan M., Content J., Houssaiau F., Aarden L., Piechaczyck M., Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989; 73: 517–526
   PubMed Web of Science ®Google Scholar
• Herrmann F., Andreff M., Gruss H. J., Brach M. A., Lubbert M., Mertelsmann R. Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression. Blood 1991; 78: 2070–2074
   PubMed Web of Science ®Google Scholar
• Peschel C., Green I., Paul W. E. Interleukin-4 induces a substance in bone marrow stromal cells which reversibly inhibits factor-dependent and factor-independent cell proliferation. Blood 1989; 74: 1130–1141
   Google Scholar
• Ogo T., Otsuka T., Satoh H., Chifu Y., Nakano T., Niho Y. Effects of interleukin 4 on stromal cell-associated bone marrow culture. Exp. Hematol 1991; 19: 899–904
   PubMed Web of Science ®Google Scholar